Guide RNA expression vector under the control of human U6 (hU6) promoter.
![]() Drawn by SnapGene® software |
|
| Clone info. | Guide RNA expression vector. The CAG promoter of CS-CA-MCS (RDB05963) was replaced with the human U6 (hU6) promoter, and the gRNA scaffold sequence was cloned downstream of the hU6 promoter to generate pCS-hU6. The kanamycin/neomycin-resistance gene was PCR amplified from pCAG-HIVgp and cloned downstream of the sgRNA scaffold sequence of pCS-hU6 to generate pCS-hU6-Neo(V2). |
|---|---|
| Vector backbone | CS-CA-MCS (RDB05963) (plasmid) |
| Selectable markers | Ampicillin (E. coli), Neomycin (mammalian cell) |
| Growth conditions | LB, 37℃ |
| Depositor|Developer | Okae, Hiroaki | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
| Ordering forms | Order form [Credit Card Payment MTA, for use for not-for-profit academic purpose [Word Please visit Ordering instruction.[link] |
|---|---|
| Terms and conditions for distribution | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Shimizu, T. et al. Proc. Natl. Acad. Sci. U.S.A. 120 (51): e2311372120, 2023). For use of the BIOLOGICAL RESOURCE by a for-profit organization or for use of the BIOLOGICAL RESOURCE for for-profit research by not-for-profit organization, the RECIPIENT must obtain a prior written consent from the Kumamoto University (kico-mta@jimu. kumamoto-u.ac.jp) Additional terms and conditions: Regarding lentivirus vector: The RECIPIENT agrees to expressly describe Dr. Hiroyuki Miyoshi as the Developer of the lentivirus vector. The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit academic purpose. |
| Remarks | Remember that you will be working with samples containing infectious virus. |
[open/close]| 必要書類 | 提供依頼書 提供同意書 (MTA, 非営利学術目的用)[Word 手続きの概要は、「レンチウイルスベクターの提供申し込み」をご覧ください。 |
|---|---|
| MTAに書く使用条件 | 利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する(Shimizu, T. et al. Proc. Natl. Acad. Sci. U.S.A. 120 (51): e2311372120, 2023)。利用者が非営利目的の教育・研究以外の目的に用いる場合は、熊本大学 (kico-mta@jimu. kumamoto-u.ac.jp) の許可を得ること。 付加的使用条件: レンチウイルスベクターについて:本件研究材料を利用した研究結果等を発表する際は、レンチウイルスベクターが三好浩之博士により開発されたことを明示する。本件リソースの使用は学術機関での学術研究に限る。 |
| 備考 | このリソースはウイルス粒子産生用のため、取扱いに注意が必要です。 |
| Catalog # | Resource name | Shipping form | Fee |
|---|---|---|---|
| RDB21099 | pCS-hU6-Neo(V2) | DNA solution |
Materials & Methods section:
| The pCS-hU6-Neo(V2) was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB21099). |
Reference section:
| Shimizu, T., Oike, A., Kobayashi, E.H., Sekiya, A., Kobayashi, N., Shibata, S., Hamada, H., Saito, M., Yaegashi, N., Suyama, M., Arima, T., Okae, H., CRISPR screening in human trophoblast stem cells reveals both shared and distinct aspects of human and mouse placental development. Proc. Natl. Acad. Sci. U.S.A. 120 (51): e2311372120 (2023). PMID 38085778. [PubMed] [Article] [RRC of NBRP] |
Further references such as user reports and related articles (go to bottom)
Original, user report and related articles
| original | Shimizu, T., CRISPR screening in human trophoblast stem cells reveals both shared and distinct aspects of human and mouse placental development. Proc. Natl. Acad. Sci. U.S.A. 120 (51): e2311372120 (2023). PMID 38085778. [PubMed] [Article] [RRC of NBRP] |
|---|
Featured content